Notable Labs, Ltd.
NTBL · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | -0.00 | 5.79 | -5.24 |
| FCF Yield | -334.39% | -125.54% | -0.31% | -0.70% |
| EV / EBITDA | 0.39 | 0.65 | -303.60 | -145.33 |
| Quality | ||||
| ROIC | -84.60% | -55.01% | -251.88% | -70.46% |
| Gross Margin | 36.45% | -14,425.00% | -468.77% | -72.23% |
| Cash Conversion Ratio | 1.22 | 0.81 | 0.94 | 0.97 |
| Growth | ||||
| Revenue 3-Year CAGR | 2.84% | -79.45% | -20.26% | 973,193.09% |
| Free Cash Flow Growth | -17.96% | 24.60% | 33.87% | -78.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.68 | 1.39 | 0.03 | 0.47 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | -233.17 |
| Efficiency | ||||
| Inventory Turnover | 0.07 | 0.00 | 3.52 | 0.00 |
| Cash Conversion Cycle | 2,238.54 | 4,399.95 | 18.92 | -323.03 |